Hint mode is switched on Switch off

Bellicum Pharmaceuticals, ordinary share
BPXA, US0794814048

Add a stock to WL
Choose all Reset all
Bellicum Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

  • Issuer
  • Full borrower / issuer name
    Bellicum Pharmaceuticals, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BLCM
  • Placement
    18.12.2014
  • Lock up period
    180
  • Number of papers
    7,350,000
  • Volume of raised funds
    139.65 mln USD
  • Final placement price
    19 USD
  • Price change since placement date
    -100%
  • By capitalization
    491.14 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BLCM
  • Placement
    22.03.2017
  • Lock up period
    180
  • Number of papers
    5,000,000
  • Volume of raised funds
    71.85 mln USD
  • Placement share
    15.55%
  • Final placement price
    14.37 USD
  • Price change since placement date
    -100%
  • By capitalization
    462.08 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BLCM
  • Placement
    18.04.2018
  • Lock up period
    180
  • Number of papers
    8,000,000
  • Volume of raised funds
    60 mln USD
  • Placement share
    19.38%
  • Final placement price
    7.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    309.64 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BLCM
  • Placement
    30.10.2020
  • Lock up period
    180
  • Number of papers
    1,040,000
  • Volume of raised funds
    6.27 mln USD
  • Placement share
    17.05%
  • Final placement price
    6.03 USD
  • Price change since placement date
    -100%
  • By capitalization
    36.75 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Indicators

News

23/02/2024 Bellicum Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
20/02/2024 Bellicum Pharmaceuticals: Completion Of Acquisition Or Disposition Of Assets, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
30/01/2024 Bellicum Pharmaceuticals: Other Events, Financial Statements And Exhibits
24/01/2024 Bellicum Pharmaceuticals: Unregistered Sales Of Equity Securities, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Submission Of Matters To A Vote Of Security Holders, Other Events, Financial Statements And Exhibits
14/12/2023 Bellicum Pharmaceuticals: Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.